RCS - Smarttech247 Group - Smarttech247 Signs New Three-Year Contract

Smarttech247Announcement

01/11/2023 07:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231101:nRSA9438Ra&default-theme=true

RNS Number : 9438R  Smarttech247 Group PLC  01 November 2023

RNS Reach

1 November 2023

Smarttech247 Group PLC

 

("Smarttech247", the "Group" or the "Company")

 

Smarttech247 Signs New Three-Year Contract

 

Order signed with global pharmaceutical solutions organisation

 

Smarttech247 (AIM: S247), a multi-award-winning provider of AI-enhanced
cybersecurity services providing automated managed detection and response for
a portfolio of international clients, is pleased to announce that it has
signed a new deal with a global pharmaceutical solutions organisation, based
in the USA, worth approximately €900,000 over three years.

 

As part of the contract, Smarttech247 will deploy its AI-enhanced VisionX
platform, a comprehensive cybersecurity solution that will help the client
strengthen its security posture. VisionX is an all-encompassing cybersecurity
platform, which includes 24/7 managed detection and response, security
information and event management, and other key cybersecurity services.

 

Raluca Saceanu, Chief Executive Officer of Smarttech247, commented:

 

"We are delighted to be chosen as a trusted cybersecurity partner to one of
the largest global pharmaceutical solutions organisations. The pharmaceutical
industry faces unique challenges in safeguarding critical and sensitive data,
and we are committed to ensuring that we provide the highest level of
cybersecurity protection and support.

 

"With the VisionX platform at their disposal, we will be able to greatly
elevate its cybersecurity defences, ensuring the integrity of its critical
data, and the protection of its intellectual property."

 

- Ends -

For further information please contact:

 Smarttech247 Group PLC                               Tel: +353 21 206 6033
 Ronan Murphy, Executive Chairman

 Raluca Saceanu, Chief Executive Officer

 Nicholas Lee, Finance Director
 SPARK Advisory Partners Limited - Nominated Adviser  Tel: + 44 (0) 20 3368 3550
 Mark Brady / Adam Dawes
 Shard Capital - Joint Broker                         Tel: +44 (0) 20 7186 9900
 Damon Heath
 Fortified Securities - Joint Broker                  Tel: +44 7493 989014
 Guy Wheatley, CFA
 Yellow Jersey PR                                     Tel: +44 (0) 20 3004 9512

 Sarah Hollins / Annabelle Wills / Bessie Elliot

 

About Reach announcements

Reach is an investor communication service aimed at assisting listed and
unlisted (including AIM quoted) companies to distribute media
only/non-regulatory news releases such as marketing messages, corporate and
product information into the public domain. An RNS Regulatory announcement is
required to be notified under the AIM Rules for Companies.

About Smarttech247

Smarttech247 is a multi-award winning automated MDR (Managed Detection &
Response) company. Its platform is trusted by international organisations and
provides threat intelligence with managed detection and response to provide
actionable insights, 24/7 threat detection, investigation and response.

The Group's services are geared towards proactive prevention and it achieves
this by utilising the latest in cloud, big data analytics and machine
learning, along with an experienced incident response team. In recognition of
its innovative technology, Smarttech247 was named by Chambers Ireland
InBusiness Recognition Awards as Cyber Security Company of the Year 2023.

Smarttech247's offices are located in Ireland, United Kingdom, Romania, Poland
and the USA. The Company was admitted to trading on AIM on 15 December 2022.

 For further information please visit www.smarttech247.com
(http://www.smarttech247.com)

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAMBBLTMTTJBLJ